Cardinal Health, Inc. (NYSE:CAH) Receives Consensus Rating of "Moderate Buy" from Brokerages

Key Points

• Cardinal Health, Inc. has received a consensus rating of “Moderate Buy” from analysts, with three hold ratings and twelve buy ratings from a total of fifteen rating firms.
• In the recent quarterly earnings report, Cardinal Health beat consensus EPS estimates by $0.05 but reported revenues slightly below expectations, showing a 0.5% year-over-year revenue increase.
• The company announced a quarterly dividend of $0.5107 per share, resulting in an annual yield of approximately 1.4%, with a payout ratio of 31.63%.

Shares of Cardinal Health, Inc. (NYSE:CAH - Get Free Report) have earned an average rating of "Moderate Buy" from the fifteen ratings firms that are currently covering the company, MarketBeat reports. Three equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $165.9333.

A number of research analysts have recently issued reports on the company. Leerink Partners lowered their price target on Cardinal Health from $188.00 to $186.00 and set an "outperform" rating on the stock in a report on Tuesday, August 12th. Wall Street Zen downgraded Cardinal Health from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 2nd. Robert W. Baird increased their target price on Cardinal Health from $197.00 to $203.00 and gave the company an "outperform" rating in a report on Wednesday, August 13th. Morgan Stanley reissued an "overweight" rating on shares of Cardinal Health in a report on Tuesday, August 12th. Finally, Evercore ISI lowered their target price on Cardinal Health from $200.00 to $190.00 and set an "outperform" rating on the stock in a report on Wednesday, August 13th.

Cardinal Health Price Performance

Shares of NYSE:CAH opened at $150.44 on Thursday. The company has a market cap of $35.92 billion, a P/E ratio of 23.32, a PEG ratio of 1.26 and a beta of 0.73. Cardinal Health has a 1 year low of $106.54 and a 1 year high of $168.44. The stock's fifty day moving average price is $156.54 and its 200-day moving average price is $146.51.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.03 by $0.05. The firm had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company's quarterly revenue was up .5% on a year-over-year basis. During the same period in the prior year, the company posted $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, sell-side analysts anticipate that Cardinal Health will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a $0.5107 dividend. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.4%. Cardinal Health's dividend payout ratio is currently 31.63%.

Insider Buying and Selling

In other Cardinal Health news, CEO Jason M. Hollar sold 107,705 shares of the stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.90, for a total value of $16,037,274.50. Following the transaction, the chief executive officer owned 235,901 shares of the company's stock, valued at approximately $35,125,658.90. This represents a 31.35% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Ola M. Snow sold 28,151 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total value of $4,192,809.94. Following the completion of the transaction, the insider directly owned 15,431 shares in the company, valued at approximately $2,298,293.14. This represents a 64.59% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock valued at $40,489,525 in the last 90 days. Insiders own 0.09% of the company's stock.

Institutional Trading of Cardinal Health

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Greykasell Wealth Strategies Inc. purchased a new stake in Cardinal Health in the first quarter worth about $26,000. Jones Financial Companies Lllp increased its position in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock worth $27,000 after buying an additional 14,034 shares in the last quarter. Atlantic Edge Private Wealth Management LLC increased its position in Cardinal Health by 75.0% in the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company's stock worth $29,000 after buying an additional 75 shares in the last quarter. Tompkins Financial Corp increased its position in Cardinal Health by 106.7% in the first quarter. Tompkins Financial Corp now owns 248 shares of the company's stock worth $34,000 after buying an additional 128 shares in the last quarter. Finally, Vermillion & White Wealth Management Group LLC increased its position in Cardinal Health by 55.0% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company's stock worth $34,000 after buying an additional 71 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company's stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.